Eli Lilly and Company has emerged as in the manufacturing of tirzepatide, a groundbreaking treatment for type 2 diabetes. Tirzepatide, a dual GIP and GLP-1 receptor agonist, showcases significant capacity to improve glycemic control and reduce heart disease. The intricate production method of tirzepatide involves a series of carefully controlled pr